Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03306927

Effect of Peas in Chili on Blood Glucose and Appetite Control

A Randomized, Controlled, Cross-over Trial Examining the Effect of Peas in Chili on Post-prandial Glycaemic Response and Satiety in Healthy Adults.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
St. Boniface Hospital · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study is part of a group of studies whose overall goal is to accurately define the physiochemical and structural effects of pea varieties and relate these to blood glucose attenuation and appetite related sensations in healthy human volunteers.

Detailed description

A randomized, controlled, cross-over study designed to examine the PPGR and appetite related sensations to peas in chili will be conducted at the I.H. Asper Clinical Research Institute in Winnipeg, Manitoba. Eligible participants who have provided consent will be asked to attend 4 clinic visits in a fasted state. Participants will be given vegetarian chili containing peas at 2 visits and rice at 2 visits. At each visit participants will provide 7 venous blood samples via indwelling catheter, 7 capillary blood samples via finger poke, 2 urine samples, 5 questionnaires about their appetite and a questionnaire about the acceptability of the products. At the end of each visit, participants will eat pizza ad libitum, and the amount of pizza consumed will be measured to determine if the peas influenced the amount of calories consumed at lunch. Participants will record their food/beverage intake for the rest of the day. Each visit will last approximately 3h and be separated by 3-14 days.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWhole yellow pea chiliChili containing whole yellow peas
DIETARY_SUPPLEMENTSplit yellow pea chiliChili containing split yellow peas
DIETARY_SUPPLEMENTRice chiliChili containing long grain white rice

Timeline

Start date
2017-11-08
Primary completion
2019-11-12
Completion
2025-01-01
First posted
2017-10-11
Last updated
2024-11-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03306927. Inclusion in this directory is not an endorsement.